The examples herein may be directed to a sleeve gastrectomy, and more particularly to a bougie or medical tube inserted into the stomach and used in conjunction with a sleeve gastrectomy stapler or clamp. The example devices herein may provide proper tension of the stomach tissue during clamping of the stapler or clamp during the creation of a vertical sleeve gastrectomy.
Obesity is a disease that affects a significant portion of the world's population and leads to multiple chronic medical conditions and premature death from cardiovascular events and cancer. In particular, the United States has a current, and worsening obesity epidemic. The U.S. Centers for Disease Control and Prevention (CDC) reports that over 33% of the U.S. population is obese, with a Body Mass Index (BMI) of over 30, and another 35-40% of the US population is overweight, with a BMI of 25-30. The CDC reports that the percent of the US population being either overweight or obese by 2018 will be 75%. The CDC also reports that obesity directly costs the U.S. economy $147 billion currently, and projects that the costs will approach $315 billion by 2020.
Further, obesity has environmental, genetic, and behavioral origins but is intractable to most medical and behavioral interventions. To help reduce obesity and/or facilitate weight loss, bariatric surgery may be an option for some patients that may be overweight. Typically, bariatric surgery may be an effective long-term treatment option for patients with a BMI greater than 35. Despite the 20 million patients who are eligible for weight loss surgery in the U.S., the number of procedures per year has plateaued at about 200 thousand, eliminating any public health effect of surgery.
In recent years, a popular form of bariatric surgery may include a laparoscopic vertical sleeve gastrectomy (e.g., which may remove approximately 80% of the stomach). Laparoscopic vertical sleeve gastrectomy may be a procedure that may be safer and more effective for patients eligible for weight loss surgery. In fact, it has been accepted as the surgery that should be offered to most morbidly obese patients over, for example, laparoscopic adjustable gastric banding and laparoscopic Roux-en-Y gastric bypass. As such, the surgery has been adopted by bariatric surgeons and is now the most commonly performed weight loss surgery.
Vertical sleeve gastrectomy is typically performed using standard laparoscopic equipment. The greater curvature of the stomach is mobilized using vessel-sealing devices, sealing the gastric branches of the gastroepiploic vessels and the short gastric vessels. The posterior adhesions of the stomach are also divided so the stomach is fully mobilized while the blood supply to the lesser curvature remains intact.
Following mobilization of the stomach a calibration tube is typically introduced into the stomach through the mouth. Resection is accomplished by applying a series of staples from a laparoscopic linear surgical stapler, for example, along the calibration tube in a staple line. The staple line may be important in sleeve gastrectomy as the amount of weight lost and complications or consequences may be a direct result of the quality of the resultant sleeve gastrectomy pouch formed from the staple line (e.g., the portion of the stomach not rescinded by the staple line). The complications or consequences may include gastroesophageal reflux disorder (GERD), weight loss failure or weight regain, food intolerance, staple line bleed, leak, and/or the like.
The stomach resection line is long (e.g., up to 22 cm). While the stomach is being stapled, sections of the stomach are retracted. Each section may be, for example, 3 cm in length and requires incorporation of equal amounts of the anterior and posterior sides of the stomach. Stomach tissue can be modelled as a series of ropes or elastic fibers. These must be pulled in the correct traction force vector relative to the clamp or stapler with 4 dimensions or axes of direction (i.e., up/down or anterior/posterior; left/right; caudad/cephalad; and rotation) and 1 dimension of magnitude. Maintaining proper tension during each clamp or staple is important to produce a sleeve gastrectomy pouch (e.g., from the staple line) without negatively affecting or interfering with the natural elasticity of the tissue.
To help produce a repeatable sleeve gastrectomy pouch, a sleeve gastrectomy shaping tube may be used. Unfortunately, the surgeon must still manually manipulate the stomach to apply tension while planning the resection line using existing methods.
Disclosed are embodiments of an apparatus for performing a sleeve gastrectomy, where the apparatus can include a bougie for insertion into an interior of a stomach, the bougie having a proximal bougie end and a distal bougie end, an inflation lumen having a proximal lumen end and a distal lumen end, the inflation lumen extending from the proximal bougie end through the distal bougie end, a fluid delivery system coupled with the proximal lumen end, the fluid delivery system being operably configured to deliver positive pressure in a predetermined positive pressure range into the stomach, and a monitor coupled with the proximal lumen end operably configured for the monitoring of pressure or volume within the stomach. The bougie can be operably configured to define a resection line for a sleeve gastrectomy when the predetermined positive pressure range is achieved within the stomach.
The bougie can include at least one balloon portion positioned at the distal bougie end. The inflation lumen can be used for both inflation and suction. The fluid delivery system can be a hand pump or a foot pump. The monitor can be a visual indicator or an audible indicator. The monitor can include a control system for metering a fluid delivered through the inflation lumen. The bougie can include at least one sensor coupled with the distal bougie end for monitoring a pressure or volume within the stomach. The distal bougie end can include a shaping portion that can be a balloon or an articulating tip. The distal bougie end can include an overtube. The inflation lumen can be a multi-lumen catheter. The predetermined positive pressure range can be from 15 mmHG to 20 mmHG.
Disclosed are embodiments of an apparatus for performing a sleeve gastrectomy, where the apparatus can include a bougie for insertion into an interior of a stomach, the bougie having a proximal bougie end and a distal bougie end, an inflation lumen having a proximal lumen end and a distal lumen end, the inflation lumen extending from the proximal bougie end through the distal bougie end, a fluid delivery system coupled with the proximal lumen end, the fluid delivery system being operably configured to deliver a predetermined range of positive pressure into the stomach, and a control system coupled with the proximal lumen end for the metering and monitoring of pressure or volume within the stomach. The bougie can be operably configured to cooperate with a stapler or clamp to define a resection line for a sleeve gastrectomy when the predetermined positive pressure range is achieved within the stomach.
Embodiments of a system for performing a sleeve gastrectomy can include a first medical device, the first medical device having a bougie for insertion into an interior of a stomach, the bougie having a proximal bougie end and a distal bougie end, an inflation lumen having a proximal lumen end and a distal lumen end, the inflation lumen extending from the proximal bougie end through the distal bougie end, a pump coupled with the proximal lumen end, the pump being operably configured to deliver a predetermined positive pressure range into the stomach, a monitor coupled with the proximal lumen end for the monitoring of pressure or volume of the stomach, and a shaping portion, the shaping portion being positioned at the distal bougie end, wherein the shaping portion is operably configured to position a portion of the stomach. The system can include a second medical device, the second medical device being a stapler or clamp positioned externally on the stomach laterally adjacent to the first medical device. In the system, the first medical device and the second medical device can be operably configured to define a resection line for a sleeve gastrectomy when the predetermined positive pressure range is achieved within the stomach and the second medical device can be operably configured to clamp the stomach along the resection line.
Example methods for performing a sleeve gastrectomy can include the steps of providing a first medical device including a tube for insertion into an interior of a stomach, the tube having a proximal end and a distal end, the distal end comprising a shaping portion; providing an inflation lumen for the introduction of positive pressure into the stomach; providing a second medical device, the second medical device being a stapler or clamp positioned externally on the stomach laterally adjacent to the first medical device; introducing positive pressure into the stomach via the inflation lumen; defining a resection line for a sleeve gastrectomy, wherein the resection line is defined at least partially by the position of the second medical device relative to the first medical device when a predetermined positive pressure range is provided via the inflation lumen; and clamping the stomach using the second medical device along the resection line.
Methods can include a bougie including the inflation lumen. The first medical device can comprise a bougie having a first balloon portion, the first balloon portion having a first balloon inflation lumen. The first balloon portion can be a non-compliant balloon having a predetermined shape in an inflated configuration. Methods can include an indicator associated with the predetermined positive pressure range of the stomach being achieved. The indicator can be a visual or audible indicator signaling that a positive pressure within the stomach is below the predetermined positive pressure range, above the predetermined positive pressure range, or within the predetermined positive pressure range. The predetermined positive pressure range can be from 1 mmHG to 25 mmHG. The predetermined positive pressure range can be from 15 mmHg to 20 mm Hg. The method can include providing a release for when a pressure within the stomach is greater than the predetermined positive pressure range. The first medical device can include a suction portion and an inflation portion, where the suction portion is operably configured to urge a first portion of the stomach proximate the suction portion and the inflation portion is operably configured to inflate the stomach to the predetermined positive pressure range. The suction portion can be positioned proximate the GE junction of the stomach. The suction portion can be positioned proximate the antrum of the stomach. The suction portion of the first medical device can extend from a portion proximate the GE junction of the stomach to a portion proximate the antrum of the stomach. The inflation lumen can be selectively configured to provide suction. The distal end of the first medical device can include an articulating member, the articulating member being operably configured to position the antrum relative to the second medical device.
Example methods where defining a resection line comprises applying a first amount of compression to the stomach with the second medical device when the positive pressure is introduced into the stomach, and applying a second amount of compression to the stomach when pressure within the stomach has reached the predetermined positive pressure range, wherein the second amount of compression is greater than the first amount of compression and the second amount of compression is operably configured to immovably retain the stomach. Example methods where the step of clamping includes providing a first clamping force with the second medical device prior to the resection line being defined, and a second clamping force with the second medical device after the resection line is defined to immovably secure the stomach therein. Example methods where the step of clamping includes first clamping a lower portion of the stomach, defining the resection line, and clamping the full length of the stomach using the second medical device. Example methods where the step of clamping the stomach with the second medical device comprises stapling the stomach and resecting a portion of the stomach.
In example methods, the first medical device can comprise a plurality of balloon portions. The distal end of the first medical device can be operably configured to articulate. The first medical device can include at least one sensor to measure the pressure or volume within the stomach. The first medical device or the second medical device include a sensor to measure tension, pressure, or volume of the stomach.
Example methods in accordance with embodiments described herein can include the steps of providing a first medical device including a tube for insertion into an interior of a stomach, the tube having a proximal end, a distal end, and at least one balloon portion, the distal end comprising a shaping portion; providing an inflation lumen for the introduction of positive pressure into the stomach, wherein the inflation lumen is coupled with a pump, a pressure gauge, and a pressure release valve; providing a second medical device, the second medical device being a stapler or clamp positioned externally on the stomach laterally adjacent to the first medical device; introducing positive pressure into the stomach via the inflation lumen until a predetermined range of pressure is achieved; defining a resection line for a sleeve gastrectomy, wherein the resection line is defined at least partially by the position of the second medical device relative to the first medical device when the predetermined positive pressure range is achieved; clamping the stomach using the second medical device along the resection line; stapling the stomach using the second medical device along the resection line; and resecting a portion of the stomach using the second medical device to form a sleeve gastrectomy.
Example methods can include a bougie, the bougie including the inflation lumen. The first medical device can comprise a bougie having at least one balloon portion, the at least one balloon portion having at least one balloon inflation lumen. Example methods can include an indicator for determining when the predetermined positive pressure range of the stomach has being achieved. The indicator can be a visual or audible indicator signaling that a positive pressure within the stomach is below the predetermined threshold range, above the predetermined threshold range, or within the predetermined threshold range. The predetermined positive pressure range can be from 1 mmHG to 25 mmHG. The predetermined positive pressure range can be from 15 mmHg to 20 mmHg.
In example methods, the first medical device can include a suction portion and an inflation portion, where the suction portion is operably configured to urge a first portion of the stomach proximate the suction portion and the inflation portion is operably configured to inflate the stomach to the predetermined positive pressure range. The suction portion can be positioned proximate the GE junction of the stomach, proximate the antrum of the stomach, or can extend from a portion proximate the GE junction of the stomach to a portion proximate the antrum of the stomach. The inflation lumen can be selectively configured to provide suction. The distal end of the first medical device can include an articulating member, the articulating member being operably configured to position the antrum relative to the second medical device. The first medical device can include at least one sensor to measure pressure or volume within the stomach.
The present disclosure will be more readily understood from a detailed description of some example embodiments taken in conjunction with the following figures:
Various non-limiting embodiments of the present disclosure will now be described to provide an overall understanding of the principles of the structure, function, and use of the apparatuses, systems, methods, and processes disclosed herein. One or more examples of these non-limiting embodiments are illustrated in the accompanying drawings. Those of ordinary skill in the art will understand that systems and methods specifically described herein and illustrated in the accompanying drawings are non-limiting embodiments. The features illustrated or described in connection with one non-limiting embodiment may be combined with the features of other non-limiting embodiments. Such modifications and variations are intended to be included within the scope of the present disclosure.
Reference throughout the specification to “various embodiments,” “some embodiments,” “one embodiment,” “some example embodiments,” “one example embodiment,” or “an embodiment” means that a particular feature, structure, or characteristic described in connection with any embodiment is included in at least one embodiment. Thus, appearances of the phrases “in various embodiments,” “in some embodiments,” “in one embodiment,” “some example embodiments,” “one example embodiment,” or “in an embodiment” in places throughout the specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures or characteristics may be combined in any suitable manner in one or more embodiments.
As described herein, systems and/or methods may be provided for performing a sleeve gastrectomy without disturbing the natural tension lines of the stomach tissue. Additionally, the systems and/or methods described herein may allow for proper sizing of the resulting sleeve gastrectomy pouch. Referring to
Although some examples herein describe the second medical device 300 as a stapler, the disclosure is not so limited. For example, the second medical device 300 may be a clamp, such as a full length 23 cm clamp configured to extend the full length of the stomach. The second medical device 300 may include a first jaw 302 or first clamp member and a second jaw 304 or second clamp member. The anatomical structure has a first side and a second side. In an embodiment, the first jaw 302 may have a first end, a second end and a cartridge housing a plurality of staples, the cartridge having a cartridge face that may be positionable on the first side of the stomach, and the second jaw 304 may have a first end, a second end, and an anvil having an anvil face that may be positionable on the second side of the stomach. The second medical device may include an end effector (e.g., including the jaws 302, 304) having a distal end 306 and a proximal end 308. Examples of suitable second medical devices are disclosed in U.S. Pat. Nos. 9,936,953, 10,278,707, and 10,548,597, each of which is hereby incorporated herein by reference in its entirety.
The first medical device 100 may be a shaping bougie, catheter, or tube, such as an orogastric tube. With reference to
Still referring to
The shaping portion 104, in combination with positive pressure in the stomach lumen, may enable the stomach tissue to have a proper and uniform tension applied to the stomach wall when the second medical device 300 is clamped to the stomach. The tension may be uniform or symmetric around a diameter (e.g., a transverse cross-section) of the resultant sleeve. For example, the first medical device 100 may be placed with the balloon 114 adjacent the incisura angularis 20 in the deflated state. The second medical device 300 may then be placed in apposition but not fully clamped, the balloon 114, which may be compliant or non-compliant, may be inflated to the inflated state. The stomach lumen is also inflated, as described further below, which creates uniform tension in the stomach tissue of the intended sleeve prior to clamping. Once the desired tension is reached, at a pressure of 20 mm HG for example, the second medical device 300 is clamped. After clamping, the balloon 114 may be deflated such that the first medical device 100 may be removed before or after stapling. In some embodiments, the cross-sectional area of the IA 20 in the resulting sleeve may be maintained or increased in comparison with a sleeve formed by prior methods that may cause a narrowing in the cross-sectional area of the IA 20.
According to one embodiment, the shaping portion 104 may be integrally formed as a unitary monolithic structure as part of the tube portion 102, for example, during manufacturing. In additional or alternative examples, the shaping portion 104 may be separately coupled and/or fixedly attached to the tube portion 102 and/or may include multiple separate pieces. The shaping portion 104 may be unitary or may be segmented. In various embodiments, the one or more balloons 114 can be compliant, semi-compliant, noncompliant, or combinations thereof. If the shaping portion 104 is segmented, each segment may vary in shape and size.
In use, the shaping portion 104 may be placed relative to one or more desired anatomic landmarks. The desired landmark may vary based on the type of first medical device or application. Examples of desired landmarks include the incisura angularis 20, the pylorus 14, and the gastroesophageal (GE) junction 18. The shape of the shaping portion 104 may vary based on the desired landmark. In various embodiments, the shaping portion 104 may be a cylinder positioned at the incisura angularis 20, a frustrum positioned at the pylorus 14, or a long cone or teardrop shape that can be considered a sleeve mold, although the shapes are not so limited.
In an embodiment, the system may include one or more fluid circuits, such as a fluid delivery system, to provide positive pressure to the shaping portion and/or the stomach lumen. One or both of the tube portion 102 and the shaping portion 104 may be coupled to a fluid source such as a foot pump or hand pump. For example, the tube portion 102 may define a lumen 120 extending between a distal aperture 122 or distal lumen end and a proximal aperture 124 or proximal lumen end. When in use, the distal aperture 122 may open into the stomach lumen, and the proximal aperture 124 may be coupled to a fluid source (e.g., via a connecting tube 126). The tube portion 102 may also define a lumen 128 fluidically coupling the interior of the balloon 114 (e.g., via an aperture 130) and a fluid source (e.g., via a coupling 132). The fluid may be a gas (e.g., ambient air, central air, CO2, or nitrogen) or a liquid (e.g., an aqueous solution, such as saline, or water). Where the tube portion 102 and the shaping portion 104 are coupled to separate fluid sources, the fluid sources may be the same or different. As described below, components other than the first medical device 100 may be coupled to a fluid circuit.
In various embodiments, the one or more fluid circuits or fluid delivery systems may be coupled to a pump system. For example, the tube portion 102, the shaping portion 104, and/or a separate catheter in communication with the stomach lumen can be coupled with a pneumatic pump to provide positive pressure and/or suction. For example, as shown in
The pump 142 can be associated with a monitor or control system for the monitoring and metering of the fluid to be delivered such that the stomach is not overinflated. The monitor can include a visual or audible indicator of when the stomach pressure or stomach volume if, for example, above a desirable predetermined range, below a predetermined range, or within the predetermined range. The monitor or control system can include a release valve set at a pressure above the desirable predetermined range to offgas fluid to return the stomach volume or pressure to an acceptable range. The control system may include any suitable features to provide a constant volume or pressure within the stomach, which may differ from prior techniques that insufflate the stomach to test for leaks and the like. Prior insufflation testing methods may use relatively high pressures, such as above 25 mm Hg, to test for leaks without the need to meter or maintain such a pressure within a defined range. Such pressures in insufflation test applications, which can exceed 50 mmHg to 75 mmHg may be too high for use with the presently described systems. Embodiments described herein can include suitable feedback sensors and the like with the first medical device or bougie to allow the control system to adjust pressure or volume in accordance with embodiments described herein.
In an embodiment, the first medical device may be configured to maintain a higher pressure in the shaping portion 104 than the stomach lumen during the sleeve gastrectomy procedure. The maximum pressure of the shaping portion 104 may be in a range of, for example, 40 mmHg to 70 mmHg. The maximum pressure of the stomach lumen may be, for example, up to 20 mmHg (the physiologic ‘pain’ pressure of the stomach), in a range of about 20 mmHg to about 100 mmHg, or up to 100 mmHg. If the surgery is being performed laparoscopically, the pneumoperitoneum will need to be accounted for (e.g., 10 mmHg to 20 mmHg). This pressure allows the stomach to inflate but not be unnaturally deformed. Further, the tension provided by the pressure has a direction and magnitude natural to the stomach tissue. The tension relieves the surgeon from the necessity of manipulating the tissue and potentially disrupting the natural tension pattern of the stomach tissue, although the surgeon may still manipulate the tissue manually if desired. The direction of the tension vector is generally at a right angle to the longitudinal axis of the second medical device 300 (e.g., longitudinal axis of the jaws 302, 304), which may provide a better resection line. The pressure used to inflate the shaping portion 104 may vary. In an example, the pressure used to inflate a balloon with water may be about 115 mmHg.
Referring now to
Once more than half of the inflated stomach radius resides lateral to the second medical device 300 (i.e., in a direction away from the first medical device 100), the balloon-like stomach urges the second medical device 300 to become adjacent and snug against the shaping portion 104 of the first medical device 100. As the stomach inflates (
Laplace retraction allows for each ‘rope’ or ‘elastic band’ of the stomach to be pulled in the correct direction as the positive pressure provides tension along the natural stomach distension vectors, preventing the surgeon from having to manually manipulate the stomach (e.g., using a laparoscopic grasper) in an attempt to create the desired tension. The pressure also pulls every gastric fiber simultaneously, not relying on the segments of tissue that a laparoscopic grasper can grab at one time. Additionally, if the second medical device 300 was initially positioned over a folded piece of stomach, the positive pressure can flatten out all parts of the stomach, preventing the clamping/stapling of folded stomach. Stapling folded stomach tissue can lead to staple line failure and leak. The resultant sleeve may have, for example, a diameter of 1 to 3 cm near a first landmark (e.g., the IA), 2 to 6 cm near a second landmark (e.g., the size of the antrum measured from the pylorus), and 0 to 2 cm near a third landmark (e.g., measured from the edge of the GE junction notch) of the stomach. In another example, the resultant sleeve may have a diameter of 1 cm to 2 cm at the fundus, a diameter of 2 cm to 3 cm at the body at the incisura angularis, and a diameter of 3 cm to 6 cm at the antrum.
With reference to
With further reference to
Still referring to
In some embodiments, an additional catheter or other tube separate from the first medical device 100 is in fluid communication with the stomach lumen. The catheter may provide positive pressure in the stomach lumen. In various embodiments, the catheter may also be configured to provide a suction force. For example, a needle may be inserted into the portion of the stomach to be removed during the gastrectomy procedure (“remnant portion”), where the needle is coupled to a pump capable of suction and/or inflation. A grasper may be used to control the position of the stomach, for example, when a catheter or needle is inserted other than through the esophagus.
Referring now to
With reference to
In various embodiments, the system may include one or more sensors 160, such as pressure sensors, flow sensors, volume sensors, etc. The sensors may be digital or mechanical. A sensor may be an in-line sensor. A suitable example pressure sensor is a 0-5 psi Omega™ digital pressure transducer (PX26-005GV). The one or more sensors may include a display or may be in communication with a display 400, monitor, or control system, such as one discussed below. For example, mechanical sensors may use a spring or column of fluid to display the measured pressure (e.g., stomach pressure, back-pressure on the inflated shaping portion, suction, etc.). The display may include an indicator to identify whether the measured pressure is low, high, or in an acceptable range. For example, a color-coded range can be used to correlate the measured pressure or volume in the stomach lumen to the desired tension of the stomach tissue.
In various embodiments, any sensor(s) can communicate data via a wireless or wired connection one or more of the first medical device, the second medical device, or a remote device, such as a display. For example, information collected by the sensor(s) can be transmitted using wireless connections (e.g., Bluetooth, Wi-Fi, a cellular network, a satellite, etc.) or wired connections (e.g., cable, copper or fiber optics, etc.).
The system, in some embodiments, may be configured to control or detect a volume of inflation. As discussed above, the system may include a monitor or control system for the monitoring and metering of the fluid to be delivered. The volume of inflation detected and/or controlled may be the volume of the stomach lumen and/or the volume of the shaping portion. Ultimately, the volume of the resultant sleeve may also be controlled. The fluid source may be a syringe or other container with a known volume of fluid. For example, a 60 mL or 100 mL syringe may be used as a fluid source for the inflation of the stomach lumen. The fluid source may be configured to provide an indication of the volume of fluid used to inflate the stomach lumen (e.g., measurements on a syringe or container). In another embodiment, the pump may be used to apply discrete volumes of fluid. A hand pump, for example, may have a known volume of fluid per application (e.g., squeeze). As another example, an electric pump may have a known flow rate, and the system may be configured to detect the volume used based on the time the pump was activated. In some embodiments, a flow meter or flow sensor may be used to measure the flow of fluid into the stomach lumen. Where a compressed fluid (e.g., compressed air) is used as a fluid source, the system may be configured to measure a pressure drop (e.g., with a pressure sensor) in the compressed fluid container to determine the volume of fluid used. The system may also include, in example embodiments, an integrated valve that discontinues fluid flow when a predetermined volume in the stomach lumen is reached. In an embodiment, the integrated valve may be in communication with the controls or a sensor.
In some embodiments, the system will include controls 402 for controlling the inflation and/or suction. For example, one or more of the first medical device 100, the second medical device 300, or a remote device may include controls in wireless or wired communication with the pump system. In an embodiment, the controls 402 can include a monitor or control system for the monitoring and metering of the fluid to be delivered as discussed above. In an embodiment, the second medical device 300 includes switches or buttons to control the inflation and/or suction of the balloon and inflation and/or suction inflation of the stomach lumen. The controls 402 may include, for example, a power button or a “zero” or tare button.
In various embodiments, the system may include a display 400. The display 400 may be configured to show data, such as pressure data relating to the shaping portion and/or the stomach lumen. The display 400 may be on one of the first medical device 100, the second medical device 300, or a separate display device. In an embodiment, the display device may include controls (e.g., controls 402) in wireless or wired communication with the inflation/suction system. The display 400 may also be configured to show data history (e.g., in a graph updating in real-time) or recent changes in the data. In an embodiment, the display device may have a hook or a handle. For example, the display device may be hangable from an IV pole. The display, in some embodiments, may be in communication with a camera and be configured to show the video feed (e.g., from gastroscope 156). In another embodiment, the display device may be a remote device such as a mobile phone or computer. The display 400 may include an indicator 404 to identify whether the measured pressure is low, high, or in an acceptable range. For example, a color-coded range can be used to correlate the measured pressure in the stomach lumen to the desired tension of the stomach tissue. The display 400 may be configured to provide a signal, such as an audio or visual signal. A signal may be provided for various reasons, such as when the tissue tension is at a predetermined value, if there is too much tension, if there is too little tension, etc.
In some embodiments, the relative maximum pressure of the shaping portion and the stomach lumen may be controlled based on the materials, dimensions, resistance, and fluid flow rates of the system. The system can include one or more relief valves 162. Additionally or alternatively, in an example embodiment, the first medical device 100 may include a first relief valve, such as a pop-off or check valve, set at a predetermined maximum pressure of the shaping portion 104. In an embodiment, the first relief valve may be in fluid communication with the lumen of the stomach as well as the lumen of the shaping portion 104. For example, the first relief valve may open into a lumen that opens into the stomach lumen. The first relief valve may vent the excess fluid into the lumen of the stomach. In this configuration, the shaping portion 104 will fill with fluid until the maximum pressure is reached causing additional fluid to vent into the stomach lumen, thus increasing the pressure in the stomach lumen. Due to the first relief valve, the shaping portion 104 maintains a higher pressure than that in the stomach lumen. Further, in some embodiments, the first medical device 100 or other component providing inflation may include a relief valve to prevent over-pressurization of the stomach lumen. The second relief valve may be set to a predetermined maximum pressure of the stomach. The predetermined maximum pressure of the stomach lumen is lower than the predetermined maximum pressure of the shaping portion. A suitable example of a relief valve is a flutter valve (a.k.a. duckbill or Heimlich valve). In some embodiments, a relief valve may provide an indication (e.g., audible or visible) that the predetermined pressure has been reached (e.g., maximum balloon pressure or maximum pressure in the stomach lumen).
In some embodiments, techniques or devices may be used to move more of the antrum to the remnant portion than would otherwise exist due to the positive pressure in the stomach lumen alone. The size of the antrum in the desired sleeve may be actively reduced. In an embodiment, the second medical device may be partially clamped on a bottom part of the stomach (i.e., distal relative to the first medical device, proximal relative to the second medical device). For example, the proximal end of the second medical device may be clamped from the bottom end of the stomach extending upwardly along a portion of the antrum, while the distal end of the second medical device remains unclamped. The shaping portion of the first medical device may be inflated or expanded before the first, partial clamp is made. The location of the partial clamp may be determined based on the desired size of the antrum in the resulting sleeve. The second medical device may be repositioned or angled such that the distal end of the second medical device is near the GE junction. The stomach lumen may be inflated as described above. The second medical device may be urged against the first medical device, and the remainder of the second medical device may then be clamped. Partially clamping the proximal end of the second medical device before inflating the stomach lumen allows for precise control of the size of the antrum in the resulting sleeve.
In another example embodiment, a bottom portion of the stomach may be stapled along the resection line before the stomach lumen is inflated. For example, the bottom end of the stomach extending upwardly along a portion of the antrum may be stapled. The location of the resection line and stapling may be determined based on the desired size of the antrum in the resulting sleeve. The bottom portion of the stomach may be stapled using the second medical device or a separate stapler. The shaping portion of the first medical device may be inflated or expanded before the initial stapling. Afterwards, the second medical device may be positioned or angled such that the distal end of the second medical device is near the GE junction. The stomach lumen may be inflated as described above. The second medical device may be urged against the first medical device, and the remainder of the second medical device may then be clamped. The remainder of the stomach along the resection line may be stapled. Partially stapling the bottom end of the stomach before inflating the stomach lumen allows for precise control of the size of the antrum in the resulting sleeve. Due to the partial stapling at the bottom of the stomach, the resection line may not be a straight line.
With reference to
In various embodiments, the distal end 306 of the second medical device 300 may be initially clamped from the top end of the stomach (e.g., approximately 1 cm from the GE junction) extending downwardly along a portion of the stomach, while the proximal end 308 of the second medical device 300 remains unclamped. The top end of the stomach may be clamped while the shaping portion 104 of the first medical device 100 is inflated or expanded and while the stomach lumen is inflated. The pressure in the stomach lumen may be increased after the top end of the stomach is clamped. In an embodiment, the positive pressure in the stomach lumen may be in a range of about 1 mmHg to about 5 mmHg when the top of the stomach is partially clamped, and the pressure may be increased to be in a range of about 20 mmHg to about 25 mmHg. For example, the pressure after the top end of the stomach is clamped may be increased to about 20 mmHg or about 25 mmHg. The direction of expansion of the stomach will be affected by the partial clamp at the top of the stomach. The antrum 22 will expand further due to the increased pressure causing more of the tissue to move through the second medical device 300 to the remnant side. Once the desired amount of antrum 22 remains in the sleeve, the second medical device 300 may be fully clamped. Partially clamping the distal end 306 of the second medical device 300 before inflating the stomach lumen further allows for precise control of the size of the antrum 22 in the resulting sleeve.
In some embodiments, the proximal end 112 of the intragastric section 110 of the first medical device 100 may be configured to anchor the tissue at the top end of the stomach. For example, the first medical device 100 may be configured to provide suction at or near the proximal end 112. The suction may allow the first medical device 100 to hold the adjacent tissue in place. While the shaping portion 104 of the first medical device 100 is inflated or expanded and while the stomach lumen is inflated, the top end of the stomach may be suctioned to the proximal end 112 of the first medical device 100. In an embodiment, the negative pressure used to hold the stomach tissue in place may be in a range of about 20 mmHg to about 200 mmHg, in a range of about 115 mmHg to about 135 mmHg, or about 125 mmHg. The pressure in the stomach lumen may be increased after the top end of the stomach is anchored in place. In an embodiment, the positive pressure in the stomach lumen may be in a range of about 1 mmHg to about 5 mmHg when the top of the stomach is suctioned, and the pressure may be increased to be in a range of about 20 mmHg to about 25 mmHg. For example, the pressure after the top end of the stomach is suctioned in place may be increased to about 20 mmHg or about 25 mmHg. The direction of expansion of the stomach will be affected by the suction at the top of the stomach. The antrum 22 will expand further due to the increased pressure causing more of the tissue to move through the jaws 302, 304 of the second medical device 300 to the remnant side. Once the desired amount of antrum 22 remains in the sleeve, the second medical device 300 may be clamped, and the suction at the proximal end 112 of the first medical device 100 may be discontinued. Anchoring the top end of the stomach before inflating the stomach lumen further allows for precise control of the size of the antrum 22 in the resulting sleeve. Examples of suction being applied by the first medical device 100 are described herein (e.g.,
In various embodiments, the stomach may be overinflated such that a portion of the first medical device 100 moves partially through the jaws 302, 304 of the second medical device 300 before the second medical device 300 is clamped. Initially, the second medical device 300 is in an open position, and the stomach lumen is inflated. The pressure in the stomach lumen is increased until the tissue along the lesser curvature 16 of the stomach is tensioned to the point where it pushes at least a portion of the first medical device 100 through the open jaws 302, 304 of the second medical device 300. For example, a middle portion of the intragastric section 110 of the first medical device 100 may move through the jaws 302, 304. The pressure in the stomach lumen is then reduced, allowing the first medical device 100 to return to the right (or the sleeve side) of the second medical device 300. The shaping portion 104 of the first medical device 100 is then inflated or expanded. The pressure in the stomach lumen is increased to urge the second medical device 300 against the first medical device 100, as described above, and then clamped. When the stomach was inflated to the point where the first medical device 100 partially moves through the open jaws 302, 304, tissue from the antrum 22 also moves through the jaws 302, 304 to the remnant side. This process may result in more antrum tissue in the remnant side than would otherwise exist.
In various embodiments, the first medical device 100 may be configured to anchor a section of the antrum 22 to a distal portion of the first medical device 100. Afterwards, the distal portion of the first medical device 100 may be moved towards the second medical device 300. For example, the first medical device 100 may be configured to apply suction, for example, at a distal portion thereof. An example embodiment is described above in reference to
Still referring to
For clarity purposes, a shaping portion 104 is not shown in
In addition or alternative to the articulating tip 168 described above, various techniques may be used to straighten the first medical device after tissue has been anchored to it. In an embodiment, the shaping portion of the first medical device may be a non-compliant balloon material (e.g., nylon, polyester, etc.) or a semi-compliant balloon material (e.g., Pebax®, high-durometer polyurethane, etc.). Initially, while the shaping portion 104 is deflated, the tube portion 102 is inserted into the stomach and positioned against the lesser curvature 16 of the stomach through tissue manipulation. The balloon 114 may be uninflated or inflated to a low or medium pressure before suction is applied at the distal portion to anchor the tissue. In an embodiment, the initial low or medium pressure may be enough pressure to demonstrate the correct sleeve size but not enough to straighten out the balloon 114. After the tissue is anchored, the balloon may be inflated to a high pressure, which may straighten the balloon 114 and moves the antrum tissue further through the jaws 302, 402. A non-compliant or semi-compliant balloon may be used, for example, in combination with an articulating tip 168 as described above.
In some embodiments, an additional device may be used to straighten the first medical device after tissue has been anchored to it. As shown in
In various embodiments, techniques other than suction may be used to anchor tissue to a portion of the first medical device. As shown in
In various embodiments, alternative techniques may be used to apply suction to anchor tissue to a portion of the first medical device. As shown in
In addition or alternative to the suction or anchors described above, various techniques may be used to anchor tissue to a portion of the first medical device. In various embodiments, a temporary soluble adhesive coating may be included on a portion of the first medical device (e.g., on a portion of a balloon that, when expanded, is adjacent the antrum). In other embodiments, a temporary soluble adhesive may be exuded through pores on the first medical device. As shown in
In some embodiments, inflation of the stomach may be at least partially controlled from the desired remnant portion of the stomach. For example, a needle may be inserted in the stomach lumen on the opposite side of the second medical device 300 from the first medical device 100 (e.g., through the fundus 24 or body 26 near the greater curvature 28) to apply inflation or suction. As shown in
In various embodiments, the system may use dynamic feedback. The system may be configured, in some embodiments, to automatically control pressurization of the stomach lumen based on the feedback. As an example, the system may use dynamic feedback to determine when to clamp the second medical device. The second medical device may be clamped manually or automatically based on the feedback. In an embodiment, as shown in
Still referring to
Referring now to
In various embodiments, the system may use dynamic feedback to reach the desired pressure in both the shaping portion and the stomach lumen. For example, the system may adjust the inflation (e.g., add more pressure or use suction to reduce pressure) of the stomach lumen and/or the shaping portion based on feedback from the first medical device. The pressure may be adjusted manually or automatically based on the feedback. The first medical device could include one or more segments coupled to one or more sensors, such as with the configurations in
In various embodiments, feedback other than backpressure on the first medical device may be used to determine when to clamp the second medical device. For example, the first medical device may be configured to determine whether the tissue surrounding the first medical device is properly tensioned. The first medical device may be configured to measure suction in zones along the length of the first medical device. The shaping portion, for example, can include more than one sets of suction apertures (or other openings as discussed above). The suctions apertures may be arranged in zones or separate segments. For example, as shown in
It will be recognized that the number and configuration of suction zones may vary. For example, with reference to
With reference to
While several devices and components thereof have been discussed in detail above, it should be understood that the components, features, configurations, and methods of using the devices discussed are not limited to the contexts provided above. In particular, components, features, configurations, and methods of use described in the context of one of the devices may be incorporated into any of the other devices. Furthermore, not limited to the further description provided below, additional and alternative suitable components, features, configurations, and methods of using the devices, as well as various ways in which the teachings herein may be combined and interchanged, will be apparent to those of ordinary skill in the art in view of the teachings herein.
Versions of the devices described above may be actuated mechanically or electromechanically (e.g., using one or more electrical motors, solenoids, etc.). However, other actuation modes may be suitable as well including but not limited to pneumatic and/or hydraulic actuation, etc. Various suitable ways in which such alternative forms of actuation may be provided in a device as described above will be apparent to those of ordinary skill in the art in view of the teachings herein.
Versions of the devices described above may have various types of construction. By way of example only, any of the devices described herein, or components thereof, may be constructed from a variety of metal and/or plastic materials.
Having shown and described various versions in the present disclosure, further adaptations of the methods and systems described herein may be accomplished by appropriate modifications by one of ordinary skill in the art without departing from the scope of the present invention. Several of such potential modifications have been mentioned, and others will be apparent to those skilled in the art. For instance, the examples, versions, geometrics, materials, dimensions, ratios, steps, and the like discussed above are illustrative and are not required. Accordingly, the scope of the present invention should be considered in terms of the following claims and is understood not to be limited to the details of structure and operation shown and described in the specification and drawings.
This application is a continuation of U.S. patent application Ser. No. 17/089,619, filed Nov. 4, 2020, which claims the priority benefit of U.S. Provisional Patent Application No. 62/930,254, filed Nov. 4, 2019, each of which is hereby incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
848126 | Roosevelt | Mar 1907 | A |
1413896 | Brix | Apr 1922 | A |
2659371 | Schnee | Nov 1953 | A |
2686520 | Jarvis et al. | Aug 1954 | A |
3017637 | Sampson | Jan 1962 | A |
3490675 | Green et al. | Jan 1970 | A |
3551987 | Wilkinson | Jan 1971 | A |
3877434 | Ferguson | Apr 1975 | A |
4216891 | Behlke | Aug 1980 | A |
4269190 | Behney | May 1981 | A |
4319576 | Rothfuss | Mar 1982 | A |
4354628 | Green | Oct 1982 | A |
4442964 | Becht | Apr 1984 | A |
4458681 | Hopkins | Jul 1984 | A |
4494057 | Hotta | Jan 1985 | A |
4520817 | Green | Jun 1985 | A |
4527724 | Chow et al. | Jul 1985 | A |
4558699 | Bashour | Dec 1985 | A |
4605001 | Rothfuss et al. | Aug 1986 | A |
4605004 | Di Giovanni et al. | Aug 1986 | A |
4608981 | Rothfuss et al. | Sep 1986 | A |
4610383 | Rothfuss et al. | Sep 1986 | A |
4632290 | Green et al. | Dec 1986 | A |
4633861 | Chow et al. | Jan 1987 | A |
4676774 | Semm et al. | Jun 1987 | A |
4679557 | Opie et al. | Jul 1987 | A |
4705038 | Sjostrom et al. | Nov 1987 | A |
4784137 | Kulik et al. | Nov 1988 | A |
4803985 | Hill | Feb 1989 | A |
4819853 | Green | Apr 1989 | A |
4848637 | Pruitt | Jul 1989 | A |
4930503 | Pruitt | Jun 1990 | A |
4941623 | Pruitt | Jul 1990 | A |
4951861 | Schulze et al. | Aug 1990 | A |
4976721 | Blasnik et al. | Dec 1990 | A |
4978049 | Green | Dec 1990 | A |
5040715 | Green et al. | Aug 1991 | A |
5136220 | Philipp | Aug 1992 | A |
5152744 | Krause et al. | Oct 1992 | A |
5176651 | Allgood et al. | Jan 1993 | A |
5205459 | Brinkerhoff et al. | Apr 1993 | A |
5219111 | Bilotti et al. | Jun 1993 | A |
5221036 | Takase | Jun 1993 | A |
5222961 | Nakao et al. | Jun 1993 | A |
5258009 | Conners | Nov 1993 | A |
5307976 | Olson et al. | May 1994 | A |
5308576 | Green et al. | May 1994 | A |
5312410 | Miller et al. | May 1994 | A |
5327914 | Shlain | Jul 1994 | A |
5333772 | Rothfuss et al. | Aug 1994 | A |
5345949 | Shlain | Sep 1994 | A |
5389098 | Tsuruta et al. | Feb 1995 | A |
5395030 | Kuramoto et al. | Mar 1995 | A |
5395034 | Allen et al. | Mar 1995 | A |
5413267 | Solyntjes et al. | May 1995 | A |
5415334 | Williamson et al. | May 1995 | A |
5431323 | Smith et al. | Jul 1995 | A |
5443475 | Auerbach et al. | Aug 1995 | A |
5452836 | Huitema et al. | Sep 1995 | A |
5452837 | Williamson et al. | Sep 1995 | A |
5456401 | Green et al. | Oct 1995 | A |
5465895 | Knodel et al. | Nov 1995 | A |
5465896 | Allen et al. | Nov 1995 | A |
5469840 | Tanii et al. | Nov 1995 | A |
5470006 | Rodak | Nov 1995 | A |
5470009 | Rodak | Nov 1995 | A |
5480089 | Blewett | Jan 1996 | A |
5485952 | Fontayne | Jan 1996 | A |
5487500 | Knodel et al. | Jan 1996 | A |
5496333 | Sackier et al. | Mar 1996 | A |
5503638 | Cooper et al. | Apr 1996 | A |
5507426 | Young et al. | Apr 1996 | A |
5507773 | Huitema et al. | Apr 1996 | A |
5514098 | Pfoslgraf et al. | May 1996 | A |
5531744 | Nardella et al. | Jul 1996 | A |
5549621 | Bessler et al. | Aug 1996 | A |
5551622 | Yoon | Sep 1996 | A |
5554169 | Green et al. | Sep 1996 | A |
5560530 | Bolanos et al. | Oct 1996 | A |
5562702 | Huitema et al. | Oct 1996 | A |
5571116 | Bolanos et al. | Nov 1996 | A |
5571131 | Ek et al. | Nov 1996 | A |
5586711 | Plyley et al. | Dec 1996 | A |
5597107 | Knodel et al. | Jan 1997 | A |
5630540 | Blewett | May 1997 | A |
5632432 | Schulze et al. | May 1997 | A |
5636780 | Green et al. | Jun 1997 | A |
5662667 | Knodel | Sep 1997 | A |
5676674 | Bolanos et al. | Oct 1997 | A |
5689159 | Culp et al. | Nov 1997 | A |
5697542 | Knodel et al. | Dec 1997 | A |
5702409 | Rayburn et al. | Dec 1997 | A |
5704534 | Huitema et al. | Jan 1998 | A |
5732871 | Clark et al. | Mar 1998 | A |
5762256 | Mastri et al. | Jun 1998 | A |
5779130 | Alesi et al. | Jul 1998 | A |
5779132 | Knodel et al. | Jul 1998 | A |
5782396 | Mastri et al. | Jul 1998 | A |
5797538 | Heaton et al. | Aug 1998 | A |
5810240 | Robertson | Sep 1998 | A |
5814055 | Knodel et al. | Sep 1998 | A |
5819240 | Kara | Oct 1998 | A |
5820009 | Melling et al. | Oct 1998 | A |
5865361 | Milliman et al. | Feb 1999 | A |
5868760 | McGuckin, Jr. | Feb 1999 | A |
5871135 | Williamson, IV et al. | Feb 1999 | A |
5901895 | Heaton et al. | May 1999 | A |
5902312 | Frater et al. | May 1999 | A |
5954259 | Viola et al. | Sep 1999 | A |
5964394 | Robertson | Oct 1999 | A |
5980248 | Kusakabe et al. | Nov 1999 | A |
5988479 | Palmer | Nov 1999 | A |
6032849 | Mastri et al. | Mar 2000 | A |
6048330 | Atala | Apr 2000 | A |
6099551 | Gabbay | Aug 2000 | A |
6264087 | Whitman | Jul 2001 | B1 |
6270507 | Callicrate | Aug 2001 | B1 |
6315184 | Whitman | Nov 2001 | B1 |
6325810 | Hamilton et al. | Dec 2001 | B1 |
6488196 | Fenton | Dec 2002 | B1 |
6505768 | Whitman | Jan 2003 | B2 |
6511490 | Robert | Jan 2003 | B2 |
6616446 | Schmid | Sep 2003 | B1 |
6716233 | Whitman | Apr 2004 | B1 |
6793652 | Whitman et al. | Sep 2004 | B1 |
6835199 | McGuckin et al. | Dec 2004 | B2 |
RE38708 | Bolanos et al. | Mar 2005 | E |
6953138 | Dworak et al. | Oct 2005 | B1 |
6978921 | Shelton, IV et al. | Dec 2005 | B2 |
6986451 | Mastri et al. | Jan 2006 | B1 |
6988649 | Shelton, IV et al. | Jan 2006 | B2 |
7025791 | Levine et al. | Apr 2006 | B2 |
7032799 | Viola et al. | Apr 2006 | B2 |
7037344 | Kagan et al. | May 2006 | B2 |
7044353 | Mastri et al. | May 2006 | B2 |
7070083 | Jankowski | Jul 2006 | B2 |
7128253 | Mastri et al. | Oct 2006 | B2 |
7134587 | Schwemberger et al. | Nov 2006 | B2 |
7175648 | Nakao | Feb 2007 | B2 |
7207472 | Wukusick et al. | Apr 2007 | B2 |
7225964 | Mastri et al. | Jun 2007 | B2 |
7229428 | Gannoe et al. | Jun 2007 | B2 |
7235089 | McGuckin, Jr. | Jun 2007 | B1 |
7258262 | Mastri et al. | Aug 2007 | B2 |
7278562 | Mastri et al. | Oct 2007 | B2 |
7278563 | Green | Oct 2007 | B1 |
7288100 | Molina Trigueros | Oct 2007 | B2 |
7308998 | Mastri et al. | Dec 2007 | B2 |
RE40237 | Bilotti et al. | Apr 2008 | E |
7398908 | Holsten et al. | Jul 2008 | B2 |
7401721 | Holsten et al. | Jul 2008 | B2 |
7404508 | Smith et al. | Jul 2008 | B2 |
7407075 | Holsten et al. | Aug 2008 | B2 |
7407076 | Racenet et al. | Aug 2008 | B2 |
7422138 | Bilotti et al. | Sep 2008 | B2 |
7434716 | Viola | Oct 2008 | B2 |
7434717 | Shelton, IV et al. | Oct 2008 | B2 |
7438209 | Hess et al. | Oct 2008 | B1 |
7455676 | Holsten et al. | Nov 2008 | B2 |
7467740 | Shelton, IV et al. | Dec 2008 | B2 |
7472815 | Shelton, IV et al. | Jan 2009 | B2 |
7481349 | Holsten et al. | Jan 2009 | B2 |
7500979 | Hueil et al. | Mar 2009 | B2 |
7506791 | Omaits et al. | Mar 2009 | B2 |
7510107 | Timm et al. | Mar 2009 | B2 |
7549564 | Boudreaux | Jun 2009 | B2 |
7549654 | Anderson et al. | Jun 2009 | B2 |
7565993 | Milliman et al. | Jul 2009 | B2 |
7588175 | Timm et al. | Sep 2009 | B2 |
7588176 | Timm et al. | Sep 2009 | B2 |
7588177 | Racenet | Sep 2009 | B2 |
7604151 | Hess et al. | Oct 2009 | B2 |
7617961 | Viola | Nov 2009 | B2 |
7635074 | Olson et al. | Dec 2009 | B2 |
7641091 | Olson et al. | Jan 2010 | B2 |
7645285 | Cosgrove et al. | Jan 2010 | B2 |
7658312 | Vidal et al. | Feb 2010 | B2 |
7665647 | Shelton, IV et al. | Feb 2010 | B2 |
7669746 | Shelton, IV | Mar 2010 | B2 |
7669747 | Weisenburgh, II et al. | Mar 2010 | B2 |
7673781 | Swayze et al. | Mar 2010 | B2 |
7673782 | Hess et al. | Mar 2010 | B2 |
7690547 | Racenet et al. | Apr 2010 | B2 |
7694864 | Okada et al. | Apr 2010 | B2 |
7704264 | Ewers et al. | Apr 2010 | B2 |
7708684 | Demarais et al. | May 2010 | B2 |
7717312 | Beetel | May 2010 | B2 |
7726537 | Olson et al. | Jun 2010 | B2 |
7726538 | Holsten et al. | Jun 2010 | B2 |
7726539 | Holsten et al. | Jun 2010 | B2 |
7731072 | Timm et al. | Jun 2010 | B2 |
7735703 | Morgan et al. | Jun 2010 | B2 |
7744613 | Ewers et al. | Jun 2010 | B2 |
7758493 | Gingras | Jul 2010 | B2 |
7770774 | Mastri et al. | Aug 2010 | B2 |
7775967 | Gertner | Aug 2010 | B2 |
D624182 | Thouement | Sep 2010 | S |
7793812 | Moore et al. | Sep 2010 | B2 |
7794475 | Hess et al. | Sep 2010 | B2 |
7815092 | Whitman et al. | Oct 2010 | B2 |
7819896 | Racenet | Oct 2010 | B2 |
7828188 | Jankowski | Nov 2010 | B2 |
7837079 | Holsten et al. | Nov 2010 | B2 |
7846149 | Jankowski | Dec 2010 | B2 |
7857184 | Viola | Dec 2010 | B2 |
7866525 | Scirica | Jan 2011 | B2 |
7866528 | Olson et al. | Jan 2011 | B2 |
7871416 | Phillips | Jan 2011 | B2 |
7891531 | Ward | Feb 2011 | B1 |
7891533 | Green et al. | Feb 2011 | B2 |
7913893 | Mastri et al. | Mar 2011 | B2 |
7918869 | Saadat et al. | Apr 2011 | B2 |
7934630 | Shelton, IV et al. | May 2011 | B2 |
7955340 | Michlitsch et al. | Jun 2011 | B2 |
7959050 | Smith et al. | Jun 2011 | B2 |
7963907 | Gertner | Jun 2011 | B2 |
7966799 | Morgan et al. | Jun 2011 | B2 |
7992757 | Wheeler et al. | Aug 2011 | B2 |
7997469 | Olson et al. | Aug 2011 | B2 |
8016176 | Kasvikis et al. | Sep 2011 | B2 |
8020741 | Cole et al. | Sep 2011 | B2 |
8028884 | Sniffin et al. | Oct 2011 | B2 |
8033442 | Racenet et al. | Oct 2011 | B2 |
8034077 | Smith et al. | Oct 2011 | B2 |
8052697 | Phillips | Nov 2011 | B2 |
8056788 | Mastri et al. | Nov 2011 | B2 |
8061577 | Racenet et al. | Nov 2011 | B2 |
8062236 | Soltz | Nov 2011 | B2 |
8066168 | Vidal et al. | Nov 2011 | B2 |
8070034 | Knodel | Dec 2011 | B1 |
8070036 | Knodel | Dec 2011 | B1 |
8087563 | Milliman et al. | Jan 2012 | B2 |
8091756 | Viola | Jan 2012 | B2 |
8096459 | Ortiz et al. | Jan 2012 | B2 |
8113406 | Holsten et al. | Feb 2012 | B2 |
8132704 | Whitman et al. | Mar 2012 | B2 |
8141762 | Bedi et al. | Mar 2012 | B2 |
8147506 | Ortiz et al. | Apr 2012 | B2 |
8167186 | Racenet et al. | May 2012 | B2 |
8172122 | Kasvikis et al. | May 2012 | B2 |
8186560 | Hess et al. | May 2012 | B2 |
8196795 | Moore et al. | Jun 2012 | B2 |
8205780 | Sorrentino et al. | Jun 2012 | B2 |
8210415 | Ward | Jul 2012 | B2 |
8216159 | Leiboff | Jul 2012 | B1 |
8220690 | Hess et al. | Jul 2012 | B2 |
8226602 | Quijana et al. | Jul 2012 | B2 |
8245898 | Smith et al. | Aug 2012 | B2 |
8252009 | Weller et al. | Aug 2012 | B2 |
8256655 | Sniffin et al. | Sep 2012 | B2 |
8276801 | Zemlok et al. | Oct 2012 | B2 |
8292153 | Jankowski | Oct 2012 | B2 |
8308725 | Bell et al. | Nov 2012 | B2 |
8317070 | Hueil et al. | Nov 2012 | B2 |
8322455 | Shelton, IV et al. | Dec 2012 | B2 |
8328061 | Kasvikis | Dec 2012 | B2 |
8328064 | Racenet et al. | Dec 2012 | B2 |
8343175 | Ewers et al. | Jan 2013 | B2 |
8348129 | Bedi et al. | Jan 2013 | B2 |
8348130 | Shah et al. | Jan 2013 | B2 |
8348131 | Omaits et al. | Jan 2013 | B2 |
8353436 | Kasvikis | Jan 2013 | B2 |
8360297 | Shelton, IV et al. | Jan 2013 | B2 |
8365973 | White et al. | Feb 2013 | B1 |
8365976 | Hess et al. | Feb 2013 | B2 |
8382775 | Bender et al. | Feb 2013 | B1 |
8393513 | Jankowski | Mar 2013 | B2 |
8393514 | Shelton, IV et al. | Mar 2013 | B2 |
8403956 | Thompson et al. | Mar 2013 | B1 |
8408442 | Racenet et al. | Apr 2013 | B2 |
8424739 | Racenet et al. | Apr 2013 | B2 |
8439244 | Holcomb et al. | May 2013 | B2 |
8439246 | Knodel | May 2013 | B1 |
8449560 | Roth et al. | May 2013 | B2 |
8453912 | Mastri et al. | Jun 2013 | B2 |
8453913 | Laurent et al. | Jun 2013 | B2 |
8464923 | Shelton, IV | Jun 2013 | B2 |
8465507 | Cosgrove et al. | Jun 2013 | B2 |
8469252 | Holcomb et al. | Jun 2013 | B2 |
8469977 | Balbierz et al. | Jun 2013 | B2 |
8479969 | Shelton, IV | Jul 2013 | B2 |
8485412 | Shelton, IV et al. | Jul 2013 | B2 |
8496155 | Knodel | Jul 2013 | B2 |
8496156 | Sniffin et al. | Jul 2013 | B2 |
8499993 | Shelton, IV et al. | Aug 2013 | B2 |
8523041 | Ishitsuki et al. | Sep 2013 | B2 |
8529585 | Jacobs et al. | Sep 2013 | B2 |
8540128 | Shelton, IV et al. | Sep 2013 | B2 |
8540130 | Moore et al. | Sep 2013 | B2 |
8544712 | Jankowski | Oct 2013 | B2 |
8561872 | Wheeler et al. | Oct 2013 | B2 |
8573465 | Shelton, IV | Nov 2013 | B2 |
8574243 | Saadat et al. | Nov 2013 | B2 |
8579176 | Smith et al. | Nov 2013 | B2 |
8579178 | Holsten et al. | Nov 2013 | B2 |
8590762 | Hess et al. | Nov 2013 | B2 |
8596513 | Olson et al. | Dec 2013 | B2 |
8608043 | Scirica | Dec 2013 | B2 |
8608046 | Laurent et al. | Dec 2013 | B2 |
8613384 | Pastorelli et al. | Dec 2013 | B2 |
8616431 | Timm et al. | Dec 2013 | B2 |
8617185 | Bonutti et al. | Dec 2013 | B2 |
8628544 | Farascioni | Jan 2014 | B2 |
8628547 | Weller et al. | Jan 2014 | B2 |
8647350 | Mohan et al. | Feb 2014 | B2 |
8663245 | Francischelli et al. | Mar 2014 | B2 |
8668130 | Hess et al. | Mar 2014 | B2 |
8672208 | Hess et al. | Mar 2014 | B2 |
8672830 | Dlugos, Jr. et al. | Mar 2014 | B2 |
8701958 | Shelton, IV et al. | Apr 2014 | B2 |
8714429 | Demmy | May 2014 | B2 |
8720766 | Hess et al. | May 2014 | B2 |
8727197 | Hess et al. | May 2014 | B2 |
8727199 | Wenchell | May 2014 | B2 |
8733613 | Huitema et al. | May 2014 | B2 |
8740035 | Mastri et al. | Jun 2014 | B2 |
8758392 | Crainich | Jun 2014 | B2 |
8763875 | Morgan et al. | Jul 2014 | B2 |
8800838 | Shelton, IV | Aug 2014 | B2 |
8800840 | Jankowski | Aug 2014 | B2 |
8801732 | Harris et al. | Aug 2014 | B2 |
8808325 | Hess et al. | Aug 2014 | B2 |
8840004 | Holsten et al. | Sep 2014 | B2 |
8852218 | Hughett, Sr. et al. | Oct 2014 | B2 |
8864009 | Shelton, IV et al. | Oct 2014 | B2 |
8899465 | Shelton, IV et al. | Dec 2014 | B2 |
8925788 | Hess et al. | Jan 2015 | B2 |
8945163 | Voegele et al. | Feb 2015 | B2 |
8956390 | Shah et al. | Feb 2015 | B2 |
8973804 | Hess et al. | Mar 2015 | B2 |
8978956 | Schall et al. | Mar 2015 | B2 |
8991676 | Hess et al. | Mar 2015 | B2 |
8991677 | Moore et al. | Mar 2015 | B2 |
8998058 | Moore et al. | Apr 2015 | B2 |
9016541 | Viola et al. | Apr 2015 | B2 |
9033203 | Woodard, Jr. et al. | May 2015 | B2 |
9066721 | Ichihara et al. | Jun 2015 | B2 |
9084600 | Knodel et al. | Jul 2015 | B1 |
9084601 | Moore et al. | Jul 2015 | B2 |
9095339 | Moore et al. | Aug 2015 | B2 |
9113862 | Morgan et al. | Aug 2015 | B2 |
9113868 | Felder et al. | Aug 2015 | B2 |
9119627 | Cosgrove et al. | Sep 2015 | B2 |
9138226 | Racenet et al. | Sep 2015 | B2 |
9149325 | Worrell et al. | Oct 2015 | B2 |
9155528 | Bender et al. | Oct 2015 | B2 |
9168039 | Knodel | Oct 2015 | B1 |
9179911 | Morgan et al. | Nov 2015 | B2 |
9180035 | Stack et al. | Nov 2015 | B2 |
9216019 | Schmid et al. | Dec 2015 | B2 |
9254131 | Soltz et al. | Feb 2016 | B2 |
9289206 | Hess et al. | Mar 2016 | B2 |
9289207 | Shelton, IV | Mar 2016 | B2 |
9307981 | Mikkaichi et al. | Apr 2016 | B2 |
9314362 | Bender et al. | Apr 2016 | B2 |
9326768 | Shelton, IV | May 2016 | B2 |
9339442 | Tai et al. | May 2016 | B2 |
9345478 | Knodel | May 2016 | B2 |
9364225 | Sniffin et al. | Jun 2016 | B2 |
9370362 | Petty et al. | Jun 2016 | B2 |
9398917 | Whitfield et al. | Jul 2016 | B2 |
9408604 | Shelton, IV et al. | Aug 2016 | B2 |
9433411 | Racenet et al. | Sep 2016 | B2 |
9439633 | O'Dea | Sep 2016 | B2 |
9498219 | Moore et al. | Nov 2016 | B2 |
9549733 | Knodel | Jan 2017 | B2 |
9561032 | Shelton, IV et al. | Feb 2017 | B2 |
9603595 | Shelton, IV et al. | Mar 2017 | B2 |
9603598 | Shelton, IV et al. | Mar 2017 | B2 |
9615952 | Scott et al. | Apr 2017 | B2 |
9636114 | Cole et al. | May 2017 | B2 |
9675355 | Shelton, IV et al. | Jun 2017 | B2 |
9687233 | Fernandez et al. | Jun 2017 | B2 |
9700321 | Shelton, IV et al. | Jul 2017 | B2 |
9706991 | Hess et al. | Jul 2017 | B2 |
9724091 | Shelton, IV et al. | Aug 2017 | B2 |
9724093 | Farascioni et al. | Aug 2017 | B2 |
9724096 | Thompson et al. | Aug 2017 | B2 |
9730692 | Shelton, IV et al. | Aug 2017 | B2 |
9775613 | Shelton, IV et al. | Oct 2017 | B2 |
9801627 | Harris et al. | Oct 2017 | B2 |
9801628 | Harris et al. | Oct 2017 | B2 |
9808246 | Shelton, IV et al. | Nov 2017 | B2 |
9808257 | Armenteros et al. | Nov 2017 | B2 |
9820742 | Covach et al. | Nov 2017 | B2 |
9827002 | Hausen et al. | Nov 2017 | B2 |
9844370 | Viola et al. | Dec 2017 | B2 |
9848873 | Shelton, IV | Dec 2017 | B2 |
9848875 | Aronhalt et al. | Dec 2017 | B2 |
9848878 | Racenet et al. | Dec 2017 | B2 |
9855040 | Kostrzewski | Jan 2018 | B2 |
9861366 | Aranyi | Jan 2018 | B2 |
9872682 | Hess et al. | Jan 2018 | B2 |
9901344 | Moore et al. | Feb 2018 | B2 |
9901346 | Moore et al. | Feb 2018 | B2 |
9913646 | Shelton, IV | Mar 2018 | B2 |
9924947 | Shelton, IV et al. | Mar 2018 | B2 |
9936953 | Thompson et al. | Apr 2018 | B2 |
9980729 | Moore et al. | May 2018 | B2 |
9999426 | Moore et al. | Jun 2018 | B2 |
9999431 | Shelton, IV et al. | Jun 2018 | B2 |
10004505 | Moore et al. | Jun 2018 | B2 |
10045780 | Adams et al. | Aug 2018 | B2 |
10085754 | Sniffin et al. | Oct 2018 | B2 |
10130360 | Olson et al. | Nov 2018 | B2 |
10130363 | Huitema et al. | Nov 2018 | B2 |
10172616 | Murray et al. | Jan 2019 | B2 |
10194912 | Scheib et al. | Feb 2019 | B2 |
10226250 | Beckman et al. | Mar 2019 | B2 |
10231734 | Thompson et al. | Mar 2019 | B2 |
10238517 | Gingras | Mar 2019 | B2 |
10245032 | Shelton, IV | Apr 2019 | B2 |
10258334 | Adams et al. | Apr 2019 | B2 |
10265073 | Scheib et al. | Apr 2019 | B2 |
10278695 | Milo | May 2019 | B2 |
10278699 | Thompson et al. | May 2019 | B2 |
10278707 | Thompson et al. | May 2019 | B2 |
10285712 | Cosgrove, III et al. | May 2019 | B2 |
10285837 | Thompson et al. | May 2019 | B1 |
10292706 | Jankowski | May 2019 | B2 |
10307161 | Jankowski | Jun 2019 | B2 |
10307163 | Moore et al. | Jun 2019 | B2 |
10314580 | Scheib et al. | Jun 2019 | B2 |
10314589 | Shelton, IV et al. | Jun 2019 | B2 |
10342538 | Racenet et al. | Jul 2019 | B2 |
10383628 | Kang et al. | Aug 2019 | B2 |
10390826 | Badawi | Aug 2019 | B2 |
10405856 | Knodel | Sep 2019 | B2 |
10405860 | Thompson et al. | Sep 2019 | B2 |
10420559 | Marczyk et al. | Sep 2019 | B2 |
10420560 | Shelton, IV et al. | Sep 2019 | B2 |
10441283 | Thompson et al. | Oct 2019 | B1 |
10456571 | Cairns | Oct 2019 | B2 |
10470911 | Thompson et al. | Nov 2019 | B2 |
10499912 | Scheib et al. | Dec 2019 | B2 |
10537325 | Bakos et al. | Jan 2020 | B2 |
10542986 | Thompson et al. | Jan 2020 | B2 |
10548597 | Dunki-Jacobs et al. | Feb 2020 | B2 |
10624638 | Thompson et al. | Apr 2020 | B2 |
10687807 | Simms et al. | Jun 2020 | B2 |
10687810 | Shelton, IV et al. | Jun 2020 | B2 |
10687814 | Dunki-Jacobs et al. | Jun 2020 | B2 |
10716564 | Shelton, IV et al. | Jul 2020 | B2 |
10758231 | Harris et al. | Sep 2020 | B2 |
10849623 | Dunki-Jacobs et al. | Dec 2020 | B2 |
10912562 | Dunki-Jacobs et al. | Feb 2021 | B2 |
10966721 | Dunki-Jacobs et al. | Apr 2021 | B2 |
20010044656 | Williamson, IV et al. | Nov 2001 | A1 |
20020143346 | Mcguckin, Jr. et al. | Oct 2002 | A1 |
20030125734 | Mollenauer | Jul 2003 | A1 |
20030220660 | Kortenbach et al. | Nov 2003 | A1 |
20040006351 | Gannoe et al. | Jan 2004 | A1 |
20040006372 | Racenet et al. | Jan 2004 | A1 |
20040068267 | Harvie et al. | Apr 2004 | A1 |
20040181239 | Dorn et al. | Sep 2004 | A1 |
20050006432 | Racenet et al. | Jan 2005 | A1 |
20050080444 | Kraemer et al. | Apr 2005 | A1 |
20050139633 | Wukusick et al. | Jun 2005 | A1 |
20050203547 | Weller et al. | Sep 2005 | A1 |
20060011698 | Okada et al. | Jan 2006 | A1 |
20060016853 | Racenet | Jan 2006 | A1 |
20060020277 | Gostout et al. | Jan 2006 | A1 |
20060036267 | Saadat et al. | Feb 2006 | A1 |
20060085030 | Bettuchi et al. | Apr 2006 | A1 |
20060151568 | Weller et al. | Jul 2006 | A1 |
20060229665 | Wales et al. | Oct 2006 | A1 |
20060241692 | McGuckin et al. | Oct 2006 | A1 |
20070023477 | Whitman et al. | Feb 2007 | A1 |
20070027469 | Smith et al. | Feb 2007 | A1 |
20070029364 | Kruszynski et al. | Feb 2007 | A1 |
20070034666 | Holsten et al. | Feb 2007 | A1 |
20070034667 | Holsten et al. | Feb 2007 | A1 |
20070039997 | Mather et al. | Feb 2007 | A1 |
20070056932 | Whitman et al. | Mar 2007 | A1 |
20070075114 | Shelton et al. | Apr 2007 | A1 |
20070083233 | Ortiz et al. | Apr 2007 | A1 |
20070131732 | Holsten et al. | Jun 2007 | A1 |
20070179528 | Soltz et al. | Aug 2007 | A1 |
20070194079 | Hueil et al. | Aug 2007 | A1 |
20070194080 | Swayze et al. | Aug 2007 | A1 |
20070194081 | Hueil et al. | Aug 2007 | A1 |
20070213743 | McGuckin, Jr. | Sep 2007 | A1 |
20070246505 | Pace-Floridia et al. | Oct 2007 | A1 |
20070262116 | Hueil et al. | Nov 2007 | A1 |
20080015631 | Lee et al. | Jan 2008 | A1 |
20080023522 | Olson et al. | Jan 2008 | A1 |
20080033457 | Francischelli et al. | Feb 2008 | A1 |
20080035702 | Holsten et al. | Feb 2008 | A1 |
20080041918 | Holsten et al. | Feb 2008 | A1 |
20080078800 | Hess et al. | Apr 2008 | A1 |
20080082124 | Hess et al. | Apr 2008 | A1 |
20080087707 | Jankowski | Apr 2008 | A1 |
20080097332 | Greenhalgh et al. | Apr 2008 | A1 |
20080149684 | Viola | Jun 2008 | A1 |
20080164297 | Holsten et al. | Jul 2008 | A1 |
20080169329 | Shelton et al. | Jul 2008 | A1 |
20080169332 | Shelton et al. | Jul 2008 | A1 |
20080190990 | Holsten et al. | Aug 2008 | A1 |
20080203134 | Shah et al. | Aug 2008 | A1 |
20080249404 | Mikkaichi et al. | Oct 2008 | A1 |
20080275480 | Jacobs et al. | Nov 2008 | A1 |
20080294179 | Balbierz et al. | Nov 2008 | A1 |
20080308602 | Timm et al. | Dec 2008 | A1 |
20090001122 | Prommersberger et al. | Jan 2009 | A1 |
20090001130 | Hess et al. | Jan 2009 | A1 |
20090012556 | Boudreaux et al. | Jan 2009 | A1 |
20090020584 | Soltz et al. | Jan 2009 | A1 |
20090078739 | Viola | Mar 2009 | A1 |
20090134200 | Tarinelli et al. | May 2009 | A1 |
20090173766 | Wenchell | Jul 2009 | A1 |
20090209946 | Swayze et al. | Aug 2009 | A1 |
20090209986 | Stewart et al. | Aug 2009 | A1 |
20090212088 | Okada et al. | Aug 2009 | A1 |
20090255974 | Viola | Oct 2009 | A1 |
20090261144 | Sniffin et al. | Oct 2009 | A1 |
20090308907 | Nalagatla et al. | Dec 2009 | A1 |
20100010512 | Taylor et al. | Jan 2010 | A1 |
20100072255 | Olson et al. | Mar 2010 | A1 |
20100072258 | Farascioni et al. | Mar 2010 | A1 |
20100108739 | Holsten et al. | May 2010 | A1 |
20100114124 | Kelleher et al. | May 2010 | A1 |
20100121356 | Hartmann et al. | May 2010 | A1 |
20100137904 | Wenchell | Jun 2010 | A1 |
20100145324 | Nihalani | Jun 2010 | A1 |
20100213240 | Kostrzewski | Aug 2010 | A1 |
20100256634 | Voegele et al. | Oct 2010 | A1 |
20100282820 | Kasvikis | Nov 2010 | A1 |
20100331866 | Surti et al. | Dec 2010 | A1 |
20110004062 | Asai et al. | Jan 2011 | A1 |
20110017800 | Viola | Jan 2011 | A1 |
20110071555 | McBrayer et al. | Mar 2011 | A1 |
20110084113 | Bedi et al. | Apr 2011 | A1 |
20110087279 | Shah et al. | Apr 2011 | A1 |
20110152895 | Nyuli et al. | Jun 2011 | A1 |
20110160752 | Aguirre | Jun 2011 | A1 |
20110178454 | Gagner et al. | Jul 2011 | A1 |
20110186614 | Kasvikis | Aug 2011 | A1 |
20110190791 | Jacobs et al. | Aug 2011 | A1 |
20110208211 | Whitfield et al. | Aug 2011 | A1 |
20110226837 | Baxter, III et al. | Sep 2011 | A1 |
20110278343 | Knodel et al. | Nov 2011 | A1 |
20110290851 | Shelton, IV | Dec 2011 | A1 |
20110315739 | Sniffin et al. | Dec 2011 | A1 |
20120059400 | Williamson, IV et al. | Mar 2012 | A1 |
20120080494 | Thompson et al. | Apr 2012 | A1 |
20120123463 | Jacobs | May 2012 | A1 |
20120175398 | Sandborn et al. | Jul 2012 | A1 |
20120203247 | Shelton, IV et al. | Aug 2012 | A1 |
20120234899 | Scheib et al. | Sep 2012 | A1 |
20120234900 | Swayze | Sep 2012 | A1 |
20120248169 | Widenhouse et al. | Oct 2012 | A1 |
20120277525 | O'Dea | Nov 2012 | A1 |
20120286022 | Olson et al. | Nov 2012 | A1 |
20130062394 | Smith et al. | Mar 2013 | A1 |
20130075447 | Weisenburgh, II et al. | Mar 2013 | A1 |
20130075450 | Schmid et al. | Mar 2013 | A1 |
20130092718 | Soltz et al. | Apr 2013 | A1 |
20130105549 | Holsten et al. | May 2013 | A1 |
20130131440 | Gabriel | May 2013 | A1 |
20130146638 | Mandakolathur Vasudevan et al. | Jun 2013 | A1 |
20130146641 | Shelton, IV et al. | Jun 2013 | A1 |
20130146642 | Shelton, IV et al. | Jun 2013 | A1 |
20130153625 | Felder et al. | Jun 2013 | A1 |
20130153634 | Carter et al. | Jun 2013 | A1 |
20130153642 | Felder et al. | Jun 2013 | A1 |
20130161374 | Swayze et al. | Jun 2013 | A1 |
20130165774 | Nocca | Jun 2013 | A1 |
20130172929 | Hess et al. | Jul 2013 | A1 |
20130193190 | Carter et al. | Aug 2013 | A1 |
20130214025 | Zemlok et al. | Aug 2013 | A1 |
20130245652 | Cosgrove et al. | Sep 2013 | A1 |
20130256372 | Baxter, III et al. | Oct 2013 | A1 |
20130256375 | Shelton, IV et al. | Oct 2013 | A1 |
20130256377 | Schmid et al. | Oct 2013 | A1 |
20130284791 | Olson et al. | Oct 2013 | A1 |
20130306704 | Balbierz et al. | Nov 2013 | A1 |
20130327809 | Shelton, IV et al. | Dec 2013 | A1 |
20130334288 | Shelton, IV | Dec 2013 | A1 |
20130341374 | Shelton, IV et al. | Dec 2013 | A1 |
20140005678 | Shelton, IV et al. | Jan 2014 | A1 |
20140027493 | Jankowski | Jan 2014 | A1 |
20140046345 | Armenteros et al. | Feb 2014 | A1 |
20140074131 | Armenteros et al. | Mar 2014 | A1 |
20140081176 | Hassan | Mar 2014 | A1 |
20140082497 | Chalouhi et al. | Mar 2014 | A1 |
20140107698 | Inge | Apr 2014 | A1 |
20140110457 | Zhang et al. | Apr 2014 | A1 |
20140114121 | Trivedi | Apr 2014 | A1 |
20140131418 | Kostrzewski | May 2014 | A1 |
20140131419 | Bettuchi | May 2014 | A1 |
20140144968 | Shelton, IV | May 2014 | A1 |
20140148731 | Radl | May 2014 | A1 |
20140171744 | Racenet et al. | Jun 2014 | A1 |
20140183242 | Farascioni et al. | Jul 2014 | A1 |
20140184519 | Benchenaa et al. | Jul 2014 | A1 |
20140191015 | Shelton, IV | Jul 2014 | A1 |
20140214025 | Worrell et al. | Jul 2014 | A1 |
20140231489 | Balbierz et al. | Aug 2014 | A1 |
20140239037 | Boudreaux et al. | Aug 2014 | A1 |
20140257353 | Whitman et al. | Sep 2014 | A1 |
20140263570 | Hopkins et al. | Sep 2014 | A1 |
20140276932 | Williams et al. | Sep 2014 | A1 |
20140291379 | Schellin et al. | Oct 2014 | A1 |
20150048141 | Felder et al. | Feb 2015 | A1 |
20150083780 | Shelton, IV et al. | Mar 2015 | A1 |
20150157318 | Beardsley et al. | Jun 2015 | A1 |
20150173755 | Baxter, III et al. | Jun 2015 | A1 |
20150173762 | Shelton, IV et al. | Jun 2015 | A1 |
20150209034 | Viola et al. | Jul 2015 | A1 |
20150265276 | Huitema et al. | Sep 2015 | A1 |
20150297224 | Hall et al. | Oct 2015 | A1 |
20150297227 | Huitema et al. | Oct 2015 | A1 |
20150320423 | Aranyi | Nov 2015 | A1 |
20150351764 | Shelton, IV | Dec 2015 | A1 |
20160058447 | Posada et al. | Mar 2016 | A1 |
20160058594 | Armenteros et al. | Mar 2016 | A1 |
20160066916 | Overmyer et al. | Mar 2016 | A1 |
20160067074 | Thompson | Mar 2016 | A1 |
20160089148 | Harris et al. | Mar 2016 | A1 |
20160166256 | Baxter, III et al. | Jun 2016 | A1 |
20160183945 | Shelton, IV et al. | Jun 2016 | A1 |
20160199061 | Shelton, IV et al. | Jul 2016 | A1 |
20160199088 | Shelton, IV et al. | Jul 2016 | A1 |
20160213302 | Frushour | Jul 2016 | A1 |
20160235409 | Shelton, IV et al. | Aug 2016 | A1 |
20160242768 | Moore et al. | Aug 2016 | A1 |
20160242769 | Moore et al. | Aug 2016 | A1 |
20160242770 | Moore et al. | Aug 2016 | A1 |
20160242783 | Shelton, IV et al. | Aug 2016 | A1 |
20160262744 | Milo et al. | Sep 2016 | A1 |
20160262750 | Hausen et al. | Sep 2016 | A1 |
20160262921 | Balbierz et al. | Sep 2016 | A1 |
20160270792 | Sniffin et al. | Sep 2016 | A1 |
20160324527 | Thompson et al. | Nov 2016 | A1 |
20160354085 | Shelton, IV et al. | Dec 2016 | A1 |
20160367250 | Racenet et al. | Dec 2016 | A1 |
20170007248 | Shelton, IV et al. | Jan 2017 | A1 |
20170014125 | Shelton, IV et al. | Jan 2017 | A1 |
20170055991 | Kang | Mar 2017 | A1 |
20170086847 | DiNardo et al. | Mar 2017 | A1 |
20170095251 | Thompson et al. | Apr 2017 | A1 |
20170105728 | Scheib et al. | Apr 2017 | A1 |
20170172571 | Thompson et al. | Jun 2017 | A1 |
20170231633 | Marczyk et al. | Aug 2017 | A1 |
20170290588 | Thompson et al. | Oct 2017 | A1 |
20170303952 | Nativ et al. | Oct 2017 | A1 |
20170319210 | Moore et al. | Nov 2017 | A1 |
20170333041 | Moore et al. | Nov 2017 | A1 |
20170360447 | Armenteros et al. | Dec 2017 | A1 |
20170367697 | Shelton, IV et al. | Dec 2017 | A1 |
20180014826 | Scheib et al. | Jan 2018 | A1 |
20180036000 | Terada et al. | Feb 2018 | A1 |
20180036005 | Covach et al. | Feb 2018 | A1 |
20180092641 | Aranyi | Apr 2018 | A1 |
20180168620 | Huang et al. | Jun 2018 | A1 |
20180168633 | Shelton, IV et al. | Jun 2018 | A1 |
20180199939 | Thompson et al. | Jul 2018 | A1 |
20180199941 | Thompson et al. | Jul 2018 | A1 |
20180235625 | Shelton, IV et al. | Aug 2018 | A1 |
20180235626 | Shelton, IV et al. | Aug 2018 | A1 |
20180280020 | Hess et al. | Oct 2018 | A1 |
20180317905 | Olson et al. | Nov 2018 | A1 |
20190000455 | Adams et al. | Jan 2019 | A1 |
20190046186 | Dunki-Jacobs et al. | Feb 2019 | A1 |
20190046189 | Dunki-Jacobs et al. | Feb 2019 | A1 |
20190046190 | Dunki-Jacobs et al. | Feb 2019 | A1 |
20190046191 | Dunki-Jacobs et al. | Feb 2019 | A1 |
20190046192 | Dunki-Jacobs et al. | Feb 2019 | A1 |
20190046193 | Dunki-Jacobs et al. | Feb 2019 | A1 |
20190105042 | Huitema et al. | Apr 2019 | A1 |
20190133577 | Weadock et al. | May 2019 | A1 |
20190150924 | Thompson et al. | May 2019 | A1 |
20190209173 | Thompson et al. | Jul 2019 | A1 |
20190209175 | Thompson et al. | Jul 2019 | A1 |
20190224029 | Thompson et al. | Jul 2019 | A1 |
20190261985 | Adams et al. | Aug 2019 | A1 |
20190261991 | Beckman et al. | Aug 2019 | A1 |
20190269408 | Jankowski | Sep 2019 | A1 |
20190274677 | Shelton, IV | Sep 2019 | A1 |
20190274678 | Shelton, IV | Sep 2019 | A1 |
20190274679 | Shelton, IV | Sep 2019 | A1 |
20190274680 | Shelton, IV | Sep 2019 | A1 |
20190307450 | Thompson et al. | Oct 2019 | A1 |
20190343519 | Thompson et al. | Nov 2019 | A1 |
20190380742 | Hall et al. | Dec 2019 | A1 |
20190388092 | Thompson et al. | Dec 2019 | A1 |
20200008964 | Thompson et al. | Jan 2020 | A1 |
20200015822 | Marczyk et al. | Jan 2020 | A1 |
20200054326 | Harris et al. | Feb 2020 | A1 |
20200100790 | DiNardo et al. | Apr 2020 | A1 |
20200205810 | Posey et al. | Jul 2020 | A1 |
20200205827 | Bakos et al. | Jul 2020 | A1 |
20200214703 | Thompson et al. | Jul 2020 | A1 |
20200229818 | Thompson et al. | Jul 2020 | A1 |
20200268385 | Dunki-Jacobs et al. | Aug 2020 | A1 |
20200297344 | Dunki-Jacobs et al. | Sep 2020 | A1 |
20200305865 | Shelton, IV | Oct 2020 | A1 |
20200305868 | Shelton, IV | Oct 2020 | A1 |
20200305869 | Shelton, IV | Oct 2020 | A1 |
20200305873 | Dunki-Jacobs et al. | Oct 2020 | A1 |
20200390443 | Thompson et al. | Dec 2020 | A1 |
Number | Date | Country |
---|---|---|
2663002 | Oct 2009 | CA |
140552 | May 1985 | EP |
399699 | Nov 1990 | EP |
503662 | Sep 1992 | EP |
666057 | Aug 1995 | EP |
669104 | Aug 1995 | EP |
399699 | Nov 1995 | EP |
503662 | Jun 1997 | EP |
1090592 | Apr 2001 | EP |
1616526 | Jan 2006 | EP |
1769766 | Apr 2007 | EP |
1774916 | Apr 2007 | EP |
1806101 | Jul 2007 | EP |
1875868 | Jan 2008 | EP |
1875870 | Jan 2008 | EP |
1938759 | Jul 2008 | EP |
2005896 | Dec 2008 | EP |
2005897 | Dec 2008 | EP |
2005898 | Dec 2008 | EP |
2005899 | Dec 2008 | EP |
2005900 | Dec 2008 | EP |
2005901 | Dec 2008 | EP |
1774916 | Feb 2009 | EP |
2019633 | Feb 2009 | EP |
2090247 | Aug 2009 | EP |
2111803 | Oct 2009 | EP |
2245993 | Nov 2010 | EP |
2319424 | May 2011 | EP |
2382928 | Nov 2011 | EP |
2019633 | Aug 2012 | EP |
2731895 | Sep 1996 | FR |
2298905 | Sep 1996 | GB |
0154594 | Aug 2001 | WO |
03094747 | Nov 2003 | WO |
2007009099 | Jan 2007 | WO |
2007019268 | Feb 2007 | WO |
2007102152 | Sep 2007 | WO |
2008039238 | Apr 2008 | WO |
2008039249 | Apr 2008 | WO |
2008039250 | Apr 2008 | WO |
2008039270 | Apr 2008 | WO |
2008042021 | Apr 2008 | WO |
2008042022 | Apr 2008 | WO |
2008042043 | Apr 2008 | WO |
2008042044 | Apr 2008 | WO |
2008042045 | Apr 2008 | WO |
2008094210 | Aug 2008 | WO |
2008141288 | Nov 2008 | WO |
2009038550 | Mar 2009 | WO |
2010011661 | Jan 2010 | WO |
2011044032 | Apr 2011 | WO |
2011044032 | Jun 2011 | WO |
2011094700 | Aug 2011 | WO |
2012141679 | Oct 2012 | WO |
2013151888 | Oct 2013 | WO |
2014026170 | Feb 2014 | WO |
2014085099 | Jun 2014 | WO |
2015063609 | May 2015 | WO |
2015153324 | Oct 2015 | WO |
2015153340 | Oct 2015 | WO |
2016033221 | Mar 2016 | WO |
Entry |
---|
AtriCure, Inc.; 510(k) Summary for AtriClip LAA Exclusion System with preloaded Gillinov-Cosgrove Clip; published Jun. 10, 2010; 6 pages. |
De Petz, A; Aseptic Technic of Stomach Resections; 86 Annals of Surgery 388; Sep. 1927; 5 pages. |
Dept. of Health and Human Services; CMS Description of Open Left Atrial Appendage Occlusion with “U” Fastener Implant; Mar. 9, 2011; 1 page. |
European Search Report received in European Application No. 15774247; dated Dec. 23, 2016; 11 pages. |
Examination Report received in Australian Application No. 2015241193; dated Dec. 11, 2018; 5 pages. |
Examination Report received in Australian Application No. 2015241267; dated Feb. 25, 2019; 6 pages. |
Examination Report received in Australian Application No. 2016208416; dated May 18, 2017; 4 pages. |
Examination Report received in Australian Application No. 2018203527; dated Oct. 22, 2018; 5 pages. |
Examination Report received in European Application No. 15772561; dated Oct. 29, 2018; 7 pages. |
Harrah, J. D.; A Lung Clamp for Use with Mechanical Staplers; 28 The Annals of Thoracic Surgery 489; Nov. 1979; 2 pages. |
International Preliminary Report on Patentability and Written Opinion of the International Searching Authority received in Application No. PCT/US2018/046743; dated Feb. 18, 2020; 17 pages. |
International Preliminary Report on Patentability and Written Opinion of the International Searching Authority received in International Patent App. No. PCT/US2015/048740; dated Mar. 7, 2017; 8 pages. |
International Search Report and Written Opinion of the International Searching Authority received in International Patent App. No. PCT/US2014/070869; dated Apr. 21, 2015; 17 pages. |
International Search Report and Written Opinion of the International Searching Authority received in International Patent App. No. PCT/US2015/022904; dated Jun. 25, 2015; 6 pages. |
International Search Report and Written Opinion of the International Searching Authority received in International Patent App. No. PCT/US2015/022990; dated Sep. 30, 2015; 10 pages. |
International Search Report and Written Opinion of the International Searching Authority received in International Patent App. No. PCT/US2015/048740; dated Feb. 17, 2016; 12 pages. |
International Search Report and Written Opinion of the International Searching Authority received in International Patent App. No. PCT/US2018/046743; dated Dec. 4, 2018; 20 pages. |
Jacobs, M. et al.; Laparoscopic sleeve gastrectomy: a retrospective review of 1- and 2-year results; Surg Endosc. Apr. 2010; 24(4):781-5; doi: 10.1007/s00464-009-0619-8; Epub Aug. 19, 2009; abstract only; 2 pages. |
LAAx, Inc.; 510(k) Summary for TigerPaw(R) System; published Oct. 29, 2010; 6 pages. |
Parikh, M. et al.; Surgical Strategies That May Decrease Leak After Laparoscopic Sleeve Gastrectomy; 257 Annals of Surgery 231; Feb. 2013; 7 pages. |
Parker, G.; A New Stomach Clamp; 26 Postgrad Med. J. 550; Oct. 1950; 1 page. |
Pfiedler Enterprises; Science of Stapling: Urban Legend and Fact; Jun. 4, 2012; 38 pages. |
Regan, J. P. et al.; Early Experience with Two-Stage Laparoscopic Roux-en-Y Gastric Bypass as an Alternative in the Super-Super Obese Patient; Obes Surg; 13(6):861-4; Dec. 1, 2003; abstract only; 2 pages. |
Search Report received in Chinese Application No. 201480075706.2; dated Nov. 28, 2018; 3 pages. |
Steichen, F. M. et al.; Stapling in Surgery; Figures 1-11C; Year Book Medical Publishers, Inc.; 1984; 3 pages. |
Supplementary European Search Report received in European Application No. 14872137; dated Mar. 28, 2017; 15 pages. |
Supplementary European Search Report received in European Application No. 15772561; dated Mar. 15, 2017; 8 pages. |
Supplementary Partial European Search Report received in European Application No. 14872137; dated Dec. 12, 2016; 5 pages. |
Zuckerman, B. D., Food and Drug Administration; Letter to AtriCure, Inc. Addressing Indication for Use of AtriClip LAA Exclusion System w/Pre-loaded Gillnov-Cosgrove Clip; Jun. 10, 2010; 3 pages. |
International Search Report and Written Opinion of the International Searching Authority received in International Patent App. No. PCT/US2020/058960; dated Feb. 2, 2021; 16 pages. |
Number | Date | Country | |
---|---|---|---|
20210205106 A1 | Jul 2021 | US |
Number | Date | Country | |
---|---|---|---|
62930254 | Nov 2019 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 17089619 | Nov 2020 | US |
Child | 17212451 | US |